Progetti FP7 coordinati da "Servicio madrileno de salud"
# |
progetto |
anno |
totale costo |
contributi |
1 |
FOD-CC FRAILTY OPERATIVE DEFINITION-CONSENSUS CONFERENCE |
2010 |
533˙080.00 |
487˙034.00 |
2 |
MESENDOT Regulation of mesenchymal stem cells by vasculature and enhancement of their regenerative potential for the treatment of acute myocardial infarction |
2011 |
230˙980.00 |
230˙980.00 |
3 |
MID-FRAIL-STUDY A RANDOMIZED CLINICAL TRIAL TO EVALUATE THE EFFECTIVENESS OF A MULTI-MODAL INTERVENTION IN OLDER PEOPLE WITH TYPE 2 DIABETES ON FRAILTY AND QUALITY OF LIFE: THE MID-FRAIL STUDY |
2012 |
7˙626˙484.00 |
5˙975˙821.00 |
4 |
NRF24NDDS Non-conventional target approach for drug discovery against neurodegenerative diseases: Nrf2 upregulation |
2012 |
100˙000.00 |
100˙000.00 |
5 |
FRAILOMIC "Utility of omic-based biomarkers in characterizing older individuals at risk for frailty, its progression to disability and general consequences to health and well-being - The FRAILOMIC Initiative" |
2013 |
15˙251˙106.00 |
11˙940˙343.00 |
Altri progetti
L'Ente servicio madrileno de salud partecipato anche in questi progetti.
- R-GNOSIS (2011, participant)
- EVOTAR (2011, participant)
- NEO-CIRC (2011, participant)
- RENEB (2012, participant)
- NeuroTREMOR (2012, participant)
- BAMI (2011, participant)
- E-PREDICE (2012, participant)
- ECRIN-IA (2012, participant)
- PARASITE (2013, participant)
- IFAAM (2013, participant)
- SENATOR (2012, participant)
- NANOGENE (2013, participant)
- BESTAGEING (2013, participant)
- COPE (2013, participant)
- EUROFANCOLEN (2013, participant)
- EUTEMPE-RX (2013, participant)
- METSY (2013, participant)
- AGGRESSOTYPE (2013, participant)
- MON4STRAT (2014, participant)
- NEOVANC (2014, participant)
- MATRICS (2014, participant)
- HeartCycle (2008, participant)
- euHeart (2008, participant)
- FAST (2008, participant)
- TROCAR (2009, participant)
- EVINCI-STUDY (2009, participant)
- GP-TCM (2009, participant)
- CHAIN (2009, participant)
- DOPPLER-CIP (2009, participant)
- NEOMERO (2010, participant)
- PAR (2010, participant)
- OPTIMISE (2010, participant)
- EU-GEI (2010, participant)
- EFACTS (2010, participant)
- PERS (2010, participant)
- AMI-4EUROPE (2010, participant)
- PRESTIGE (2010, participant)
- EBM CONNECT (2010, participant)
- AIPGENE (2011, participant)
- CANCERALIA (2011, participant)